Yuki Takeyasu
Hirakata, 5731191, Japan
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 42 publications
Should supportive care be started before initiating cancer treatment?
Journal: Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
Published: May 21, 2026
Survival, toxicity, and sequencing: navigating the new first-line standard established by FLAURA2.
Journal: Translational lung cancer research
Published: February 14, 2026
Life-threatening Pneumonitis Induced by Osimertinib Monotherapy as a First-line Treatment for Epidermal Growth Factor Receptor Mutation-positive Non-small-cell Lung Cancer: A Retrospective Case-series Study.
Journal: Anticancer research
Published: February 13, 2026
AGTR1 signaling contributes to tumor immunity and therapy response in non-small cell lung cancer.
Journal: Molecular therapy. Oncology
Published: January 08, 2026
Why Cemiplimab? Defining a Unique Therapeutic Niche in First-Line Non-Small-Cell Lung Cancer with Ultra-High PD-L1 Expression and Squamous Histology.
Journal: Cancers
Published: December 10, 2025
A Prospective Observational Study of Anamorelin During Chemoimmunotherapy in Non-Small Cell Lung Cancer With Cachexia (SPIRAL-ANA).
Journal: Journal of cachexia, sarcopenia and muscle
Published: November 20, 2025
PD-L1 phenotype classification based on expression in tumor and immune cells as a potential biomarker for optimizing anti-PD-1/CTLA-4 immunotherapies in NSCLC.
Journal: Journal for immunotherapy of cancer
Published: November 17, 2025
Severe Immune-related Adverse Events and Their Effect on Survival in Patients With Advanced Non-small Cell Lung Cancer Receiving Immune Checkpoint Inhibitors.
Journal: Cancer diagnosis & prognosis
Published: September 29, 2025
Multicenter retrospective study of selpercatinib treatment for advanced or recurrent RET fusion-positive non-small cell lung cancer in Japan.
Journal: Investigational new drugs
Published: August 30, 2025
Clinical trajectory of KRAS G12C-mutated advanced non-small cell lung cancer: a single-center cohort study in Japan.
Journal: Respiratory investigation
Published: August 22, 2025
Study protocol of an open-label prospective phase II study of Durvalumab plus Carboplatin and Etoposide in advanced large cell neuroendocrine carcinoma of the lung (LOGIK2401: NECTAR study).
Journal: Cancer treatment and research communications
Published: July 29, 2025
Exploratory analysis of associations among weight loss, oral function, and dysgeusia in patients with lung cancer undergoing chemotherapy.
Journal: BMC oral health
Published: June 26, 2025
Last Updated: 09/26/2026